Carter Erin Catherine (CIK 1993078) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-07). Recent activity: Buy GCTK (32 shares), Buy GCTK (1,000 shares), Buy GCTK (386 shares), Buy GCTK (903 shares), Buy GCTK (458 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-07 | Glucotrack, Inc. (GCTK) | Director | Buy | 32 | $0 |
| 2025-10-07 | Glucotrack, Inc. (GCTK) | Director | Buy | 1,000 | $0 |
| 2025-10-07 | Glucotrack, Inc. (GCTK) | Director | Buy | 386 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 903 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 458 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 2,078 | $64,834 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 40,297 | $0 |
| 2025-03-31 | Glucotrack, Inc. (GCTK) | Director | Buy | 1,896 | $0 |
Source: SEC Form 4 filings · as of 2025-10-07